Zoetis | ZTS - Assets


Zoetis reported $15.15B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
AbbVie USD 136.46B 2.5B Mar/2026
Align Technology USD 6.31B 80.48M Mar/2026
Bayer EUR 107.94B 3.4B Mar/2026
Bristol-Myers Squibb USD 86.48B 3.56B Mar/2026
Charles River Laboratories USD 7.73B 594.89M Mar/2026
Coherus Biosciences USD 258.34M 258.18M Dec/2025
Dentsply International USD 5.23B 200M Mar/2026
Eli Lilly USD 116.58B 4.1B Mar/2026
Henry Schein USD 11.3B 89M Mar/2026
Idexx Laboratories USD 3.39B 34.74M Mar/2026
Illumina USD 6.56B 85M Mar/2026
IQVIA Holdings USD 29.68B 269M Mar/2026
J&J USD 200.89B 1.68B Mar/2026
Laboratory Of America USD 19.09B 694.4M Mar/2026
Merck USD 128.68B 8.18B Mar/2026
Neogen USD 3.36B 953K Dec/2025
Pacira USD 1.21B 56.38M Mar/2026
Perrigo USD 7.98B 551.9M Mar/2026
Pfizer USD 207.62B 542M Mar/2026
Phibro Animal Health USD 1.45B 39.56M Mar/2026
Quest Diagnostics USD 16.67B 448M Mar/2026
Sanofi EUR 128.02B 1.22B Mar/2026
Sanofi EUR 128.02B 1.22B Mar/2026
Zoetis USD 15.15B 313M Mar/2026